— Know what they know.
Not Investment Advice

2784.T

Alfresa Holdings Corporation
1W: +0.8% 1M: -4.6% 3M: +8.9% YTD: -3.6% 1Y: +25.6% 3Y: +69.8% 5Y: +40.2%
¥2,508.00 ($15.73)
+33.00 (+1.33%)
 
JPX · Healthcare · Medical - Distribution · ¥449.8B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥449.8B ($2.8B)
52W Range1897-2685.5
Volume268,000
Avg Volume302,360
Beta0.11
Dividend¥66.00
Analyst Ratings
No analyst coverage
Company Info
CEORyuji Arakawa
Employees12,517
SectorHealthcare
IndustryMedical - Distribution
IPO Date2005-09-29
1-1-3 Otemachi
Tokyo 100-0004
JP
81 3 5219 5100
About Alfresa Holdings Corporation

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms